Clinical Trials Directory

Trials / Conditions / Immunosuppression

Immunosuppression

155 registered clinical trials studyying Immunosuppression26 currently recruiting.

StatusTrialSponsorPhase
Not Yet Recruiting(TNX-1500) in Kidney Transplant Recipients
NCT07204080
Ayman Al Jurdi, MDPhase 2
Active Not RecruitingAdaptation of Lung Transplant Recipients at Extreme Altitude
NCT07479511
Medical University of Vienna
Not Yet RecruitingEvaluation of PCV21 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans
NCT06271681
VA Sierra Nevada Health Care SystemPhase 4
Not Yet RecruitingRole of MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC
NCT06024226
University Hospital, Bordeaux
RecruitingFibroscan to Guide Post Transplant Immunosuppression Minimization
NCT07206277
University of AlbertaN/A
Not Yet RecruitingHeartCare Immuno-optimization in Cardiac Allografts (MOSAIC)
NCT05459181
CareDxN/A
RecruitingEffectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus
NCT06701825
Instituto de Investigación Hospital Universitario La PazPhase 4
Not Yet RecruitingB-cell Depletion in Offspring to Women With MS Under Immunomodulatory Treatment
NCT06711354
Region Stockholm
RecruitingEvaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year
NCT06354179
University Hospital, LimogesPhase 4
CompletedEffect of Cognitive Therapy on Immunosuppressive Treatment Compliance and Motivation
NCT06879106
Bitlis Eren UniversityN/A
RecruitingEfficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
NCT05814432
Federal University of Health Science of Porto AlegrePhase 3
CompletedComparability of Fingerprick vs Venous Blood for Tacrolimus Monitoring
NCT06585293
Nottingham University Hospitals NHS Trust
RecruitingRegistry of Vaccine Responses in Immune Compromised Patients
NCT06463119
Laure Pittet, MD-PhD
Not Yet RecruitingHistamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer
NCT05810792
Sahlgrenska University HospitalPhase 2
RecruitingSafety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients
NCT06262776
Central Adelaide Local Health Network IncorporatedN/A
RecruitingTacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs
NCT06268769
Edward GeisslerPhase 4
Not Yet RecruitingEfficacy and Safety of Immunosuppressive Withdrawal After Pediatric Liver Transplantation
NCT06147375
Wei GaoN/A
CompletedAdditional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed Populations
NCT06027229
University of Wisconsin, MadisonPhase 2
CompletedPREPARE-iVAC Trial
NCT05924685
University Medical Center GroningenPhase 4
CompletedMicrosampling Assays for Immunosuppressive Drugs in Children
NCT04989686
Children's Hospital of Philadelphia
RecruitingVascularized Composite Bladder Allograft Transplantation
NCT05462561
University of Southern CaliforniaN/A
UnknownDynamic Changes of Torquetenovirus (TTV) Load in Chinese Renal Transplant Recipients
NCT05727709
Tongji Hospital
CompletedORCHARD- Optimising Home Assessment of Rural Patients
NCT05732922
University of AberdeenN/A
RecruitingTacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations
NCT05089604
University of British ColumbiaPhase 4
UnknownA Follow-up Study of Immune Dysregulation in Patients With COVID-19
NCT05669248
Qilu Hospital of Shandong University
WithdrawnMonitoring of Corticosteroids Induced Immunosuppression Using Monocyte Human Leukocyte Antigen-DR (mHLA-DR).
NCT04360772
Hospices Civils de Lyon
TerminatedImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
NCT05655546
Scripps Translational Science InstituteN/A
RecruitingStudy to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.
NCT04654988
Medical University of WarsawPhase 4
RecruitingCombined Immunosuppression for Pediatric Crohn's Disease
NCT05043870
Children's Hospital of Fudan UniversityPhase 4
RecruitingPathological Myeloid Activation After Sepsis and Trauma
NCT05616130
University of Florida
WithdrawnKidneyCare Immuno-optimization in Renal Allografts (KIRA)
NCT05423496
CareDxN/A
UnknownMetabolic and Infectious Complications Post Belatacept Conversion
NCT05316038
University Hospital, Grenoble
CompletedTacrolimus in CD3+ T Lymphocytes
NCT06342505
Erasmus Medical Center
TerminatedHigh-Dose Moderna mRNA-1273 Booster Study for Lung Transplant Recipients
NCT05280158
University of California, Los AngelesPhase 1 / Phase 2
UnknownCOvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases
NCT05236491
Paul R FortinPhase 2 / Phase 3
CompletedTorque Teno Virus: A Biomarker of Immunosuppression
NCT05756036
Queen Mary University of London
UnknownIncidence, Course and Outcome of ABMR in Kidney Transplantation
NCT05140018
University Medical Center Groningen
Active Not RecruitingEfficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients
NCT05537948
National Medical Research Center for Therapy and Preventive MedicinePhase 4
UnknownBooster Dose of COVID-19 Vaccine for Kidney Transplant Recipients Without Adequate Humoral Response
NCT04961229
dafna yahavPhase 4
Active Not RecruitingImpact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients
NCT05060991
University of California, DavisPhase 4
RecruitingImmunoinflammatory Regulation of Esketamine in Septic Patients
NCT04843982
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyPhase 4
WithdrawnEvaluation of Interaction Between Immunosuppressive Drugs and Protein-bound Uremic Toxins in Renal Transplant
NCT04963673
Centre Hospitalier Universitaire, Amiens
UnknownSirolimus in Treatment of Proteinuric Flares of Lupus Nephritis
NCT04892212
Peking Union Medical College HospitalPhase 2 / Phase 3
UnknownMycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatiti
NCT04376528
West China HospitalPhase 4
UnknownImmunosuppression Management in Renal Transplant Recipients With Transplant Excellence Based on TruGraf Test
NCT04670926
Transplant Genomics, Inc.N/A
UnknownProbiotics and Overreaching Recovery
NCT04885010
University of PadovaN/A
WithdrawnMaintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Dis
NCT04420364
Brigham and Women's HospitalPhase 2 / Phase 3
UnknownClinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases
NCT04834089
Butantan InstitutePhase 1 / Phase 2
UnknownResponses to COVID19 Vaccination in Patients With a Treatment History of Rituximab.
NCT04877496
Insel Gruppe AG, University Hospital Bern
CompletedHumoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals
NCT04858607
Medical University of Graz
UnknownSaxon SARS-CoV-2 Infection and Vaccination Study in Dialysis Patients, Solid Organ Recipients and Staff
NCT04799808
Technische Universität Dresden
CompletedMechanism of Delayed Neutrophil Apoptosis in Acute Lung Injury
NCT04607434
The First Hospital of Jilin University
CompletedInvestigation of Immune Modulation by Modern Acupuncture in Gastroenterologic Cancers
NCT04692454
Taipei Medical University WanFang HospitalN/A
RecruitingRFA Plus Carrizumab vs Carrizumab Alone for HCC
NCT04150744
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2
UnknownThe New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma
NCT04657562
National Science Centre, Poland
TerminatedRole of Children in Transmission of COVID-19 to Immunocompromised Patients
NCT04407546
Jonsson Comprehensive Cancer Center
TerminatedRisk of Hepatitis Flare in Patients With Previous Hepatitis B Virus Exposure Amongst Patients
NCT04356404
Chinese University of Hong Kong
CompletedCollection of Data of Ceftobiprole Treated Patients: Comparison of Patients With and Without Certain Diseases
NCT04170309
Advanz Pharma
CompletedOptimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Midd
NCT04542954
Hamid Al-Essa Organ Transplant Center
CompletedImmune Monitoring to Facilitate Belatacept Monotherapy
NCT04177095
Massachusetts General HospitalPhase 4
UnknownThe Effects of Microbiota Composition on Immunosuppression Protocols in Transplantation
NCT04360031
Université Catholique de Louvain
Active Not RecruitingRCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients
NCT03797196
University Medical Center GroningenPhase 4
UnknownVeloxis de Novo Kidney Transplant ECSWD
NCT03828682
Simon Tremblay, PharmD, PhDPhase 4
CompletedUse of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients
NCT04041219
Mayo ClinicPhase 4
UnknownImproving Immunosuppressive Therapy in Heart Transplantation
NCT03932539
Fondazione IRCCS Policlinico San Matteo di Pavia
UnknownBlood-Bile Ratio Tacrolimus After Liver Transplantation
NCT03882164
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
CompletedStroke-induced Immunodepression in Neurorehabilitation
NCT05889169
IRCCS National Neurological Institute "C. Mondino" Foundation
CompletedHelminth Infection During Pregnancy on Vitamin D Regulation: HELMVIT Study
NCT04324853
Centre de Recherche Médicale de Lambaréné
TerminatedExtended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisa
NCT03689075
Imperial College Healthcare NHS TrustPhase 4
CompletedEfficacy of Single Dose Anti-thymocyte Globulin in the Modulation of T Lymphocytes in Kidney Transplantation
NCT04835948
Hospital de Clinicas de Porto Alegre
UnknownComparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus )
NCT03603548
Medical University of WarsawN/A
CompletedImpact of Underlying Renal Disease and Immunosuppressive Regimen on Ovarian Reserve in Renal Patients
NCT04762615
Wroclaw Medical University
CompletedIntra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma
NCT03316274
University of California, San FranciscoEARLY_Phase 1
RecruitingRole of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arr
NCT04521790
Scientific Institute San Raffaele
UnknownTacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
NCT03386539
Boston Children's HospitalPhase 3
CompletedImprovement of Postoperative Immunosuppression in Patients Receiving Coronary Artery Bypass Grafting by TEAS
NCT02933996
ShuGuang HospitalN/A
CompletedDosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients
NCT02953873
Medical University of South CarolinaPhase 4
TerminatedProspective Cohort of Kidney Transplanted Patients Receiving an Extended Releasing Tacrolimus-Everolimus Assoc
NCT03228576
Poitiers University Hospital
CompletedHFNC Alone or Associated With NIV for Immunocompromised Patients Admitted to ICU for Acute Respiratory Failure
NCT02978300
Poitiers University HospitalN/A
UnknownFecal Calprotectin Levels in Mycophenolate Mofetil Induced Diarrhea and Treatment With Octreotide
NCT02977897
University Health Network, Toronto
CompletedOnce-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant R
NCT02954198
Medical University of South CarolinaN/A
CompletedHigh Dose vs. Standard Influenza Vaccine in Adult SOT
NCT03139565
University Health Network, TorontoPhase 3
CompletedNMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia
NCT02833805
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2
TerminatedMicrofluidics and Transcriptomics in Post Solid Organ Transplant Patients
NCT02776111
University of Florida
RecruitingThe Transplant Cohort of the German Center for Infection Research
NCT06346665
Technical University of Munich
CompletedDental Extractions Among Renal Transplant Recipients
NCT02547753
University of Sao Paulo
CompletedLiver Immune Tolerance Marker Utilization Study
NCT02541916
University of TorontoN/A
RecruitingImmunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss Therapy
NCT02310867
Linda CendalesPhase 2
TerminatedSunbit UV Measuring Device to Track Sun Behavior
NCT02221843
University of Zurich
UnknownDiagnostic Accuracy of Pleural Effusion Aspergillosis Biomarker Testing
NCT02104479
Heidelberg University
UnknownExpression of TIM-3 on Lymphocytes in Sepsis
NCT02319876
Changhai Hospital
UnknownEvaluation of Performance of An Aspergillus PCR in Tissue and Pleural Effusion Samples of Immunocompromised Pa
NCT01902030
Heidelberg University
CompletedConversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function
NCT01936519
Milton S. Hershey Medical CenterN/A
UnknownIntracoronary Analysis of Cardiac Allograft Vasculopathy by Means of Optical Coherence Tomography
NCT02254668
University of ZurichPhase 4
CompletedEffect of RANKL Inhibition on UV-induced Immunosuppression
NCT01978483
Innovaderm Research Inc.Phase 1
CompletedZinc Supplementation on Cellular Immunity in Thalassemia Major
NCT03117192
Fakultas Kedokteran Universitas IndonesiaPhase 4
CompletedBioequivalence Study of Tacrobell Capsule 1mg to Prograf Capsule 1mg
NCT01910077
Chong Kun Dang PharmaceuticalN/A
TerminatedCardiac Allograft Remodeling and Effects of Sirolimus
NCT01889992
University of NebraskaPhase 1
CompletedExtracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patie
NCT01824368
Red de Terapia CelularPhase 1 / Phase 2
RecruitingOral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)
NCT01568697
National Institute of Dental and Craniofacial Research (NIDCR)
CompletedEvaluation Of Switching From Twice Daily Tacrolimus To Once Daily Formulation On Cardiovascular Risk
NCT01702207
University of SaskatchewanPhase 4
CompletedImmunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
NCT01638559
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2
CompletedInfluence of Pantoprazole on the Bioavailability of MMF and EC-MPS
NCT01801280
Klemens BuddePhase 4
UnknownStudy to Evaluate the Safety and Efficacy of Switching Calcineurin Inhibitor to Everolimus After Kidney Transp
NCT01455649
Deise de Boni Monteiro de CarvalhoPhase 4
CompletedExpression and the Clinical Significance of Neutrophil PD-L1 During Sepsis
NCT01976884
Changhai Hospital
TerminatedEvaluate Tolerability of Myfortic®/Simulect® and Tacrolimus Without Steroids in Three Patient Populations
NCT01387659
The University of Texas Medical Branch, GalvestonN/A
CompletedEffects of Systemically Administered Hydrocortisone on the Immune System in Healthy Volunteers
NCT01281995
National Heart, Lung, and Blood Institute (NHLBI)
CompletedImmune Response to Vaccination in Patients Receiving Single Drug Immunosuppression
NCT01733056
Emory UniversityN/A
CompletedCytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant
NCT01239472
Andre Barreto PereiraPhase 4
CompletedImmunosuppression in HIV-infected Patients With Tuberculosis in Ethiopia
NCT01252537
Lund University
CompletedTBE-vaccine to Patients With Rheumatoid Arthritis Who Are Using Immunosuppressive Drugs
NCT01131910
Sormland County Council, SwedenPhase 2
CompletedEVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients
NCT01942005
Andreas Arnold
CompletedDE NOVO DONOR SPECIFIC ANTIBODIES AFTER KIDNEY TRANSPLANTATION: SINGLE-CENTER RETROSPECTIVE STUDY
NCT06425497
University of Rome Tor Vergata
CompletedSafety and Efficacy of an Inactivated and Non Adjuvanted Vaccine Against Influenza A in Renal Transplant Recip
NCT01086904
Institut National de la Santé Et de la Recherche Médicale, FrancePhase 2
UnknownSafety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adu
NCT01017172
Goethe UniversityPhase 4
CompletedSafety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation
NCT00768729
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1
TerminatedThymoglobulin Induction Therapy With Minimal Immunosuppression and Evaluation of Allograft Status
NCT00731874
Weill Medical College of Cornell UniversityPhase 4
CompletedThymoglobulin: Presence and Affect in the Central Lymphatic Compartment
NCT00714480
Swedish Medical CenterN/A
CompletedThe Differential Effects of 3 Different Immunosuppressive
NCT00729248
Northwestern University
CompletedThe Vienna Prograf and Endothelial Progenitor Cell Extension Study
NCT03751332
Medical University of ViennaPhase 4
CompletedHLA-Identical Sibling Renal Transplant Tolerance
NCT00619528
Northwestern UniversityN/A
UnknownA Study of Thymoglobulin and Tacrolimus in Liver Transplant
NCT00564538
University of NebraskaPhase 4
CompletedA Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children
NCT00626808
MedImmune LLC
CompletedImmune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive
NCT01678937
Northwestern University
CompletedPharmacokinetic Drug Interaction Between Ezetimibe and Tacrolimus After Single Dose Administration in Healthy
NCT00621699
University Medicine GreifswaldPhase 1
UnknownImmunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients
NCT00492739
University Hospital, GenevaPhase 2 / Phase 3
CompletedPharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy S
NCT00621101
University Medicine GreifswaldPhase 1
CompletedStudy of Rituximab to Treat Chronic Renal Transplant Rejection
NCT00476164
King's College LondonPhase 4
CompletedA Prospective Study on the Tolerability and Efficacy of the de Novo Use of Myfortic in Liver Transplant Recipi
NCT00336817
University of PittsburghN/A
CompletedConversion of CellCept to Myfortic: A Prospective Study in Liver Transplant Recipients
NCT00336895
University of PittsburghN/A
CompletedProtective Immunity Project 02
NCT00833651
Emory University
CompletedRenal Transplantation With Immune Monitoring
NCT00419575
Washington University School of Medicine
CompletedProtective Immunity Project 01
NCT00788021
Emory University
CompletedRandomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen
NCT00286871
Duke UniversityPhase 1
CompletedCholesterol and Fatty Acid Synthesis in Islet and Liver Transplant Patients and Effect of Dietary Intervention
NCT00947635
University of AlbertaPhase 1 / Phase 2
CompletedInfluenza Vaccination in Immunocompromized Patients
NCT00783380
Insel Gruppe AG, University Hospital BernPhase 4
CompletedHuman Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis
NCT00130637
National Eye Institute (NEI)Phase 2
CompletedMPA PK Monitoring Strategy With MMF/FK Based Immunosuppression
NCT00187941
University of FloridaEARLY_Phase 1
CompletedSystemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
NCT00116090
National Eye Institute (NEI)
UnknownFibrosis in Renal Allografts
NCT00493194
University Hospital, AntwerpPhase 4
CompletedLiver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids
NCT01137084
Shanghai Jiao Tong University School of MedicineN/A
CompletedSafety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients
NCT00240994
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2
CompletedImmune Indicators of Uveitis
NCT00089739
National Eye Institute (NEI)
CompletedSafety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients
NCT00299221
Newark Beth Israel Medical CenterPhase 4
UnknownLong-term Outcomes After Conversion to Belatacept
NCT04733131
Paris Translational Research Center for Organ Transplantation
CompletedIslet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation
NCT01123187
University Hospital, LilleN/A
UnknownSirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
NCT00166842
National Taiwan University HospitalPhase 4
CompletedSafety and Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Children Receiving Solid Organ Transpl
NCT00213265
The Hospital for Sick ChildrenPhase 3
UnknownThe Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients
NCT00166816
National Taiwan University HospitalPhase 4
CompletedStem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances
NCT00353860
National Heart, Lung, and Blood Institute (NHLBI)Phase 2
CompletedTacrolimus Versus Cyclosporine for Immunosuppression After Lung Transplantation
NCT01429844
Universitätsklinikum Hamburg-EppendorfPhase 3
CompletedThe Safety of Oka Varicella in Children Prior to Solid Organ Transplantation
NCT00213304
The Hospital for Sick ChildrenPhase 3
RecruitingCologne Cohort of Neutropenic Patients (CoCoNut)
NCT01821456
University Hospital of Cologne
CompletedTo Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets
NCT00946790
SandozPhase 1
No Longer AvailableSpecial Access for the Use of Voclosporin for Kidney Transplantation
NCT01236287
Weill Medical College of Cornell University